Feedback
Dyskeratosis Congenita, Autosomal (TERC) Sequencing
2006244
Ordering Recommendation

Refer to Additional Technical Information document.

Mnemonic
TERC FGS
Methodology
Sequencing
Performed
Varies
Reported
4-5 weeks
New York DOH Approval Status
This test is New York DOH approved.
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA). Also acceptable: Pink (K2EDTA) 
Specimen Preparation
Transport 5 mL whole blood. (Min: 2 mL) 
Storage/Transport Temperature
Room temperature. Also acceptable: Refrigerated. Protect from extreme temperatures. 
Unacceptable Conditions
 
Remarks
Clinical indication or reason for testing is required. 
Stability
Ambient: 1 week; Refrigerated: 1 week; Frozen: Unacceptable 
Reference Interval
By report
Interpretive Data


Components
Component Test Code*Component Chart NameLOINC
2006245Dyskeratosis Congenita, (TERC) Seq.
2010873Ordering Physician Name67102-4
2010874Ordering Physician Phone Number67714-6
2010885EER Dyskeratosis Congenita, AD (TERC)11526-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Dyskeratosis congenita, Autosomal dominant, DKCA1
  • Scoggins type
  • Telomerase RNA Component, TERC, hTR, TR, 3q21-28
  • TERC Gene Sequencing

Performed at GeneDx